Long noncoding RNAs are substrates for cytoplasmic capping enzyme.

Area of Science:

• Molecular Biology
• RNA Biology
• Cancer Biology

Background:

• Cytoplasmic capping is a known mechanism for protecting messenger RNAs (mRNAs) from degradation.
• Previously, uncapped mRNAs were presumed to be rapidly degraded.
• The role of cytoplasmic capping in the regulation of noncoding RNAs remained unexplored.

Purpose of the Study:

• To investigate whether long noncoding RNAs (lncRNAs) are substrates of the cytoplasmic capping enzyme (cCE).
• To determine the subcellular localization of sarcoma-associated lncRNAs.
• To assess the impact of inhibiting cCE on the abundance of uncapped lncRNAs.

Main Methods:

• Subcellular localization analysis of 14 sarcoma-associated lncRNAs in U2OS osteosarcoma cells.
• 5' rapid amplification of cDNA ends (RACE) to detect uncapped lncRNA forms.
• Inhibition of cytoplasmic capping enzyme activity.
• Analysis of public cap analysis of gene expression (CAGE) data.

Main Results:

• Inhibition of cCE led to an increase in uncapped forms of specific lncRNAs.
• Subcellular localization studies provided insights into lncRNA distribution.
• Analysis of CAGE data revealed increased prevalence of 5'-RACE cloned sequences, supporting cCE targeting.

Conclusions:

• The cytoplasmic capping enzyme (cCE) plausibly targets and caps certain long noncoding RNAs (lncRNAs).
• This suggests a novel regulatory role for cytoplasmic capping beyond mRNA stabilization.
• Further research is warranted to elucidate the functional implications of cCE activity on lncRNAs in cancer.